Stay updated with breaking news from Bridge Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Health officials see Novavax’s protein-based vaccine as a valuable alternative for people who don’t want to take messenger RNA shots from Pfizer and...
COVID-19 vaccine began arriving in mid-September, but some were charged in error. Most shots will be free through private insurance, Medicare or Medicaid or public health agencies.
(Reuters) -The U.S. Food and Drug Administration said on Tuesday it has authorized an updated version of Novavax's COVID-19 vaccine for emergency use in individuals aged 12 years and older, and the company's shares climbed more than 11%. The Maryland-based company, whose COVID vaccine is its lone marketed product, has adopted cost-cutting measures and is counting on commercial sales of its updated shot to help it stay afloat. The U.S. Centers for Disease Control and Prevention (CDC) director last month signed off on broad use of rival updated COVID vaccines from Pfizer Inc with Ger...
With the end of the public health emergency the COVID-19 vaccine is now commercial and can cost between $115 and $128 per dose.
The Food and Drug Administration (FDA) granted emergency use authorization to Novavax’s COVID-19 vaccine on Tuesday, bringing the number of immunizations effective against the current circulating strain up to three. Novavax’s vaccine, a more traditional protein-based shot that differs from the mRNA vaccines that have become commonplace, has been authorized for people 12 years of…